Literature DB >> 29532466

Academic Detailing with Provider Audit and Feedback Improve Prescribing Quality for Older Veterans.

Ann E Vandenberg1,2, Katharina V Echt1,2,3, Lawanda Kemp3, Gerald McGwin1, Molly M Perkins1,2, Anna K Mirk1,2,3.   

Abstract

Suboptimal prescribing persists as a driver of poor quality care of older veterans and is associated with risk of hospitalization and emergency department visits. We adapted a successful medication management model, Integrated Management and Polypharmacy Review of Vulnerable Elders (IMPROVE), from an urban geriatric specialty clinic to rural community-based clinics that deliver primary care. The goals were to promote prescribing quality and safety for older adults, including reduced prescribing of potentially inappropriate medications (PIMs). We augmented the original model, which involved a pharmacist-led, one-on-one medication review with high-risk older veterans, to provide rural primary care providers (PCPs) and pharmacists with educational outreach through academic detailing and tools to support safe geriatric prescribing practices, as well as individual audit and feedback on prescribing practice and confidential peer benchmarking. Twenty PCPs and 4 pharmacists at 4 rural Georgia community-based outpatient clinics participated. More than 7,000 older veterans were seen in more than 20,000 PCP encounters during the 14-month intervention period. Implementation of the IMPROVE intervention reduced PIM prescribing incidence from 9.6 new medications per 100 encounters during baseline to 8.7 after the intervention (P = .009). IMPROVE reduced PIM prevalence (proportion of encounters involving veterans who were taking at least 1 PIM) from 22.6% to 16.7% (P < .001). These approaches were effective in reducing PIMs prescribed to older veterans in a rural setting and constitute a feasible model for disseminating geriatric best practices to the primary care setting.
© 2018, Copyright the Authors Journal compilation © 2018, The American Geriatrics Society.

Entities:  

Keywords:  aged 65 and older; inappropriate prescribing; potentially inappropriate medication list; quality improvement; veterans health

Mesh:

Year:  2018        PMID: 29532466     DOI: 10.1111/jgs.15247

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  6 in total

1.  Early prescribing outcomes after exporting the EQUIPPED medication safety improvement programme.

Authors:  Camille P Vaughan; Ula Hwang; Ann E Vandenberg; Traci Leong; Daniel Wu; Melissa B Stevens; Carolyn Clevenger; Stephanie Eucker; Nick Genes; Wennie Huang; Edidiong Ikpe-Ekpo; Denise Nassisi; Laura Previl; Sandra Rodriguez; Martine Sanon; David Schlientz; Debbie Vigliotti; S Nicole Hastings
Journal:  BMJ Open Qual       Date:  2021-11

Review 2.  Effectiveness of Interventions to Reduce Potentially Inappropriate Medication in Older Patients: A Systematic Review.

Authors:  Daniela A Rodrigues; Ana I Plácido; Ramona Mateos-Campos; Adolfo Figueiras; Maria Teresa Herdeiro; Fátima Roque
Journal:  Front Pharmacol       Date:  2022-01-24       Impact factor: 5.810

3.  Influencers on deprescribing practice of primary healthcare providers in Nova Scotia: An examination using behavior change frameworks.

Authors:  Natalie Kennie-Kaulbach; Rachel Cormier; Olga Kits; Emily Reeve; Anne Marie Whelan; Ruth Martin-Misener; Fred Burge; Sarah Burgess; Jennifer E Isenor
Journal:  Med Access Point Care       Date:  2020-06-03

Review 4.  A narrative review of evidence to guide deprescribing among older adults.

Authors:  Kenya Ie; Shuichi Aoshima; Taku Yabuki; Steven M Albert
Journal:  J Gen Fam Med       Date:  2021-05-28

Review 5.  Intervention elements to reduce inappropriate prescribing for older adults with multimorbidity receiving outpatient care: a scoping review.

Authors:  Jia Qi Lee; Kate Ying; Penny Lun; Keng Teng Tan; Wendy Ang; Yasmin Munro; Yew Yoong Ding
Journal:  BMJ Open       Date:  2020-08-20       Impact factor: 2.692

6.  Virtual academic detailing (e-Detailing): A vital tool during the COVID-19 pandemic.

Authors:  Jonathan D Hoffman; Ramona Shayegani; Patrick M Spoutz; Ashley D Hillman; Jason P Smith; Daina L Wells; Sarah J Popish; Julianne E Himstreet; Jane M Manning; Mark Bounthavong; Melissa L D Christopher
Journal:  J Am Pharm Assoc (2003)       Date:  2020-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.